Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Immunoblastic Lymphadenopathy × Dexrazoxane × Clear all

Sponsor

Conditions

Sarcoma 4 Osteosarcoma 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Leukemia 2 Vomiting 1 Sarcoma, Synovial 1 Sarcoma, Ewing 1 Recurrence 1 PRETEXT I Hepatoblastoma 1 Neurofibrosarcoma 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Neuroblastoma 1 Nausea 1 Lymphoma, Large-Cell, Anaplastic 1 Localized Extraskeletal Ewing Sarcoma 1 Liposarcoma 1 Leiomyosarcoma 1 Hypersensitivity 1 Histiocytoma, Malignant Fibrous 1 Hemangiosarcoma 1 Ganglioneuroblastoma 1 Fibrosarcoma 1 Extravasations of Anthracycline Anti-cancer Agents 1 Drug-Related Side Effects and Adverse Reactions 1 Dermatofibrosarcoma 1 Degradation of Top2b and Top2a in Human by Dexrazoxane 1

Interventions

fludarabine phosphate 14 Cyclophosphamide 13 Whole-Body Irradiation 11 Peripheral Blood Stem Cell Transplantation 11 Etoposide 10 Tacrolimus 9 Mycophenolic Acid 7 Rituximab 6 Methotrexate 6 Melphalan 6 Cyclosporine 6 Busulfan 6 Antilymphocyte Serum 6 Vorinostat 4 Sirolimus 4 Prednisone 4 Lenalidomide 4 Immunohistochemistry 4 Gene Expression Profiling 4 Carboplatin 4 Vincristine 3 Microarray Analysis 3 Everolimus 3 Doxorubicin 3 Dexamethasone 3 Alemtuzumab 3 thymoglobulin 2 prednylidene 2 fludarabine 2 etoposide phosphate 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡